Deep Brain Stimulation: A New Era in Functional Neuroscience?
Journal Title: Journal of Neurology and Psychology - Year 2013, Vol 1, Issue 1
Abstract
Deep Brain Stimulation (DBS) evolved from functional stereotactic neurosurgery techniques designed to produce selective lesions of the thalamus and cerebellum [1]. In 1952, Irving S. Cooper discovered the potential of ligation therapy when he unintentionally occluded the anterior choroidal artery, causing a medial globuspallidal infarction, which, surprisingly, alleviated rest tremor, rigidity and contralateral cogwheeling. Throughout the 1950s and 1960s, techniques for ablative procedures were refined with much focus on identifying the ideal targets. The motor thalamus and globuspallidusinternus (GPi) were considered the most effective targets [2,3]. In the 1960s, L-dopa became the standard of care for Parkinson’s disease (PD) and the popularity of ablative surgeries significantly decreased. During this time, ablative surgeries were primarily limited to thalamotomy to treat tremor and pallidotomy and thalamotomy for dystonia; they were rarely done to treat PD. However, by the 1980s, the limitations (motor fluctuations and dyskinesias) of L-dopa became apparent and ablative surgeries for PD regained popularity [1,3]. Building on the experience of ablative surgeries, stimulation procedures started to become commonplace in the management of movement disorders by the 1990s. This introduced a new era in functional neuroscience for movement disorders.
Authors and Affiliations
Lin Zhang, Laura Sperry
Keywords
Related Articles
- EP ID EP194336
- DOI 10.13188/2332-3469.1000002
- Views 105
- Downloads 0
The Relationship between Stress and Diabetes Mellitus
Diabetes mellitus (DM) is a metabolic disease characterized by chronic hyperglycemia that results from an alteration of the secretion or action of insulin. This metabolic condition is not homogeneous and the World Health...
Moyamoya Disease: A Rare Sickle Cell Trait Neurological Complication
ntroduction: Sickle cell disease is an inherited blood disorder with multisystem complications, including cerebrovascular accidents primarily due to micro infarcts. However, people with sickle cell trait, the heterozygou...
Methylfolate as Monotherapy in Depression. A Pilot Randomised Controlled Trial
Background: The commonest neuropsychiatric complication of severe folate deficiency is depression. Placebo controlled trials of folates as adjunctive therapy in major depression have confirmed that they enhance the respo...
Deep Brain Stimulation: A New Era in Functional Neuroscience?
Deep Brain Stimulation (DBS) evolved from functional stereotactic neurosurgery techniques designed to produce selective lesions of the thalamus and cerebellum [1]. In 1952, Irving S. Cooper discovered the potential of li...
Differences in the Lipid Domain Organization of Erythrocyte Membranes in Patients with Schizophrenia
Gradually accumulating evidence indicates that schizophrenia may be accompanied by alterations of membrane phospholipids, however knowledge about how it affects lipid domain organization of membrane is lacking. We compar...